1. Home
  2. ATXS vs NNDM Comparison

ATXS vs NNDM Comparison

Compare ATXS & NNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • NNDM
  • Stock Information
  • Founded
  • ATXS 2008
  • NNDM 2012
  • Country
  • ATXS United States
  • NNDM Israel
  • Employees
  • ATXS N/A
  • NNDM N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • NNDM Electrical Products
  • Sector
  • ATXS Health Care
  • NNDM Technology
  • Exchange
  • ATXS Nasdaq
  • NNDM Nasdaq
  • Market Cap
  • ATXS 401.2M
  • NNDM 322.3M
  • IPO Year
  • ATXS 2015
  • NNDM N/A
  • Fundamental
  • Price
  • ATXS $4.04
  • NNDM $1.51
  • Analyst Decision
  • ATXS Strong Buy
  • NNDM
  • Analyst Count
  • ATXS 5
  • NNDM 0
  • Target Price
  • ATXS $26.60
  • NNDM N/A
  • AVG Volume (30 Days)
  • ATXS 369.7K
  • NNDM 3.2M
  • Earning Date
  • ATXS 05-08-2025
  • NNDM 06-02-2025
  • Dividend Yield
  • ATXS N/A
  • NNDM N/A
  • EPS Growth
  • ATXS N/A
  • NNDM N/A
  • EPS
  • ATXS N/A
  • NNDM N/A
  • Revenue
  • ATXS N/A
  • NNDM $57,660,000.00
  • Revenue This Year
  • ATXS N/A
  • NNDM $26.79
  • Revenue Next Year
  • ATXS N/A
  • NNDM N/A
  • P/E Ratio
  • ATXS N/A
  • NNDM N/A
  • Revenue Growth
  • ATXS N/A
  • NNDM 6.85
  • 52 Week Low
  • ATXS $3.56
  • NNDM $1.34
  • 52 Week High
  • ATXS $12.92
  • NNDM $2.75
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 28.96
  • NNDM 33.46
  • Support Level
  • ATXS $3.56
  • NNDM $1.34
  • Resistance Level
  • ATXS $4.39
  • NNDM $1.53
  • Average True Range (ATR)
  • ATXS 0.42
  • NNDM 0.08
  • MACD
  • ATXS -0.04
  • NNDM 0.02
  • Stochastic Oscillator
  • ATXS 22.61
  • NNDM 57.57

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High-fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in medical devices. The portfolio of the company includes Mechanical, Chemical, Applications, Industrial Design, and Artificial Learning areas. Nano Dimension machines serve cross-industry needs by depositing proprietary consumable conductive and dielectric materials simultaneously, while concurrently integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components, to function at an unprecedented performance.

Share on Social Networks: